HCV VACCINATIONS

摘要

The invention relates to a method for preventing or treating Hepatitis C Virus (HCV) infections, wherein a HCV vaccine comprising an effective amount of at least one HCV T-cell antigen and a polycationic compound comprising peptide bonds is administered to a human individual bi-weekly at least 3 times.